Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk

Autor: Nikita Taparia, Lucas H. Ting, Shirin Feghhi, Esther B. Lim, Nathan J. White, Annie O. Smith, Tessa Rue, Xu Wang, Nathan J. Sniadecki, Ari Karchin, Alex St. John
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Male
Platelet Aggregation
Thromboxane
Microfluidics
General Physics and Astronomy
02 engineering and technology
Platelet inhibition
P2Y12
Medicine
Platelet
lcsh:Science
Aspirin
Multidisciplinary
biology
Middle Aged
021001 nanoscience & nanotechnology
Prognosis
Platelet Glycoprotein GPIb-IX Complex
Cardiology
Female
Drug Monitoring
0210 nano-technology
medicine.drug
Adult
Blood Platelets
medicine.medical_specialty
Science
Integrin
Hemorrhage
Platelet Glycoprotein GPIIb-IIIa Complex
Myosins
General Biochemistry
Genetics and Molecular Biology

Fibrin
Article
03 medical and health sciences
Thromboxane A2
Thrombin
Internal medicine
Humans
Computer Simulation
Blood Coagulation
business.industry
General Chemistry
030104 developmental biology
Cross-Sectional Studies
biology.protein
Wounds and Injuries
lcsh:Q
business
Platelet Aggregation Inhibitors
Zdroj: Nature Communications, Vol 10, Iss 1, Pp 1-10 (2019)
Nature Communications
ISSN: 2041-1723
DOI: 10.1038/s41467-019-09150-9
Popis: Platelets contract forcefully after their activation, contributing to the strength and stability of platelet aggregates and fibrin clots during blood coagulation. Viscoelastic approaches can be used to assess platelet-induced clot strengthening, but they require thrombin and fibrin generation and are unable to measure platelet forces directly. Here, we report a rapid, microfluidic approach for measuring the contractile force of platelet aggregates for the detection of platelet dysfunction. We find that platelet forces are significantly reduced when blood samples are treated with inhibitors of myosin, GPIb-IX-V, integrin αIIbβ3, P2Y12, or thromboxane generation. Clinically, we find that platelet forces are measurably lower in cardiology patients taking aspirin. We also find that measuring platelet forces can identify Emergency Department trauma patients who subsequently require blood transfusions. Together, these findings indicate that microfluidic quantification of platelet forces may be a rapid and useful approach for monitoring both antiplatelet therapy and traumatic bleeding risk.
Platelet aggregates generate contractile forces that contribute to their cohesion and adhesion. Here, Ting et al. develop a microfluidic device to measure contractile forces generated by platelet aggregates, and find it can detect the response of platelets to pharmacological agents and predict bleeding risk in trauma patients.
Databáze: OpenAIRE